LIANY
LianBioCompany Information
- Company Name
- LianBio
- CIK
- CIK0001831283
- Category
- <br>Emerging growth company
- Ticker: Exchange
- LIANY: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- LIANY
SEC filing data through
Insider Sentiment
- Last purchase
- 2022-08-18
- Last sale
- 2024-01-02
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 3,970
Institutional Sentiment
- As of
- 2023-12-31
- Institutional shares owned
- 80,630,051
- Shares outstanding
- 107,167,691
- Ownership
- 75.24%
Earnings Market Reaction
- Filing date
- 2023-11-13
- Price on filing date
- —
- 1-month reaction
- -1.91%
- 3-month reaction
- -1.43%
Balance Sheet
Values in millions ($)| Line item | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 103 | 104 | 102 | 79 | 79 | 134 | 140 | 228 | 109 | ||||||
| Marketable Securities Current | 149 | 163 | 184 | 223 | 233 | 195 | 229 | 155 | - | ||||||
| Due From Related Parties Current | - | - | - | - | - | - | 2 | - | - | ||||||
| Prepaid Expense And Other Assets Current | 5 | 5 | 9 | 9 | 5 | 7 | 9 | 10 | 6 | ||||||
| Other Receivables Net Current | 1 | 1 | 1 | 2 | 7 | 7 | 6 | 6 | 6 | ||||||
| Assets Current | 258 | 273 | 296 | 313 | 324 | 344 | 386 | 400 | 121 | ||||||
| Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 20 | 20 | 20 | 20 | 20 | ||||||
| Property Plant And Equipment Net | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | ||||||
| Operating Lease Right Of Use Asset | 3 | 3 | 4 | 4 | 4 | 5 | 4 | 5 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 263 | 279 | 303 | 320 | 352 | 372 | 413 | 426 | 142 | ||||||
Liabilities Current | |||||||||||||||
| Accounts Payable Current | 6 | 2 | 5 | 1 | 2 | 1 | 8 | 3 | 2 | ||||||
| Accrued Liabilities Current | 16 | 17 | 17 | 20 | 18 | 18 | 15 | 10 | 13 | ||||||
| Operating Lease Liability Current | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 0 | ||||||
| Accrual For Taxes Other Than Income Taxes Current | - | - | - | - | - | - | - | - | 6 | ||||||
| Other Liabilities Current | 2 | 1 | 2 | 0 | 0 | 1 | 1 | 1 | 2 | ||||||
| Liabilities Current | 26 | 22 | 26 | 24 | 22 | 22 | 25 | 15 | 22 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 2 | 2 | 3 | 4 | 3 | 4 | 0 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Liabilities | 27 | 23 | 28 | 26 | 45 | 46 | 49 | 39 | 42 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | 0 | 353 | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | |||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 746 | 741 | 737 | 732 | 729 | 724 | 720 | 713 | 42 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -3 | -3 | -2 | -2 | -4 | -1 | -1 | 1 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -540 | -516 | -495 | -471 | -452 | -430 | -388 | -360 | -339 | ||||||
| Stockholders Equity | 236 | 222 | 274 | 260 | 307 | 326 | 331 | 387 | -253 | ||||||
| Minority Interest | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 44 | ||||||
| Liabilities And Stockholders Equity | 263 | 279 | 303 | 320 | 352 | 372 | 413 | 426 | 142 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 2,924 | 2,924 | 2,924 | 2,924 | 2,924 | 2,924 | 2,924 | 2,924 | 2,859 | ||||||
| Common Stock Shares Issued | 107 | 107 | 107 | 107 | 108 | 108 | 107 | 107 | 22 | ||||||
| Redeemable Convertible Preferred Stock | - | - | - | - | - | - | - | 0 | - | ||||||
| Shares Outstanding | 107 | 107 | 107 | 107 | 108 | 108 | 107 | 107 | 22 | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | - | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialLianBio (LIANY) — SEC Financial Statements & Analysis
LianBio (LIANY) is a pharmaceutical preparations company, incorporated in E9. LianBio trades on OTC as: LIANY. LianBio (LIANY)'s most recent SEC filing is a Form 10-Q for the period ended 2023-09-30, filed with the SEC on 2023-11-13. Based on that filing, LianBio carries a market cap of $-100.61K, a P/E ratio of 0.00x, a P/B ratio of -0.00x, an enterprise value of $-103.56M, and an EV/EBITDA multiple of 0.98x. On profitability, it posts a Return on Equity (ROE) of -32.42%, a Return on Assets (ROA) of -28.62%, and a Return on Invested Capital (ROIC) of -62.62%. Per share, it reports EPS of $-0.82, diluted EPS of $-0.82, free cash flow per share of $-0.78, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -68.03% year-over-year and EPS growth of -67.68% year-over-year. On the balance sheet, it maintains a current ratio of 10.06x, a quick ratio of 9.88x, working capital of $232.18M, a debt-to-equity ratio of 0.11x, a debt ratio of 0.1, an interest coverage ratio of -10.71x, free cash flow of $-83.99M (TTM), and net debt of $-103.46M. Figures sourced from SEC EDGAR.
- Market Cap
- $-100.61K
- P/E TTM
- 0.00x
- EPS TTM
- $-0.82
- P/B TTM
- -0.00x
- ROE TTM
- -32.42%
- ROA TTM
- -28.62%
- Debt To Equity
- 0.11x
- Free Cash Flow TTM
- $-83.99M
Data as of 2023-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is LianBio in?
LianBio (LIANY) operates in the Pharmaceutical Preparations industry.
What exchange does LIANY trade on?
LianBio (LIANY) trades on the OTC.
Where is LianBio incorporated?
LianBio is incorporated in Cayman Islands.
When was LianBio (LIANY)'s most recent SEC filing?
LianBio (LIANY)'s most recent SEC filing is a Form 10-Q for the period ended 2023-09-30, filed with the SEC on 2023-11-13.
What is LIANY's market cap?
LianBio (LIANY) has a market capitalization of $-100.61K as of 2023-09-30.
What is LIANY's P/E ratio?
LianBio (LIANY)'s trailing twelve month P/E ratio is 0.00x as of 2023-09-30.
What is LIANY's EPS (earnings per share)?
LianBio (LIANY)'s trailing twelve month EPS is $-0.82 as of 2023-09-30.
What is LIANY's ROE (return on equity)?
LianBio (LIANY)'s trailing twelve month Return on Equity (ROE) is -32.42% as of 2023-09-30.
What is LIANY's ROA (return on assets)?
LianBio (LIANY)'s trailing twelve month Return on Assets (ROA) is -28.62% as of 2023-09-30.
What is LIANY's ROIC (return on invested capital)?
LianBio (LIANY)'s trailing twelve month Return on Invested Capital (ROIC) is -62.62% as of 2023-09-30.
What is LIANY's EV/EBITDA?
LianBio (LIANY)'s trailing twelve month EV/EBITDA is 0.98x as of 2023-09-30.